De Novo EGFR ‐ALK and EGFR ‐ROS1 Co‐Mutations in NSCLC: Clinical Characteristics, Molecular Profiling, and Treatment Outcomes From a Retrospective Analysis
ABSTRACT Background De novo epidermal growth factor receptor‐anaplastic lymphoma kinase (EGFR‐ALK) and EGFR‐ROS proto‐oncogene 1 (EGFR‐ROS1) co‐mutations in non‐small‐cell lung cancer (NSCLC), conditions traditionally considered mutually exclusive. We present the first large‑scale analysis of their...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.71084 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|